Atria Wealth Solutions’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$923K Sell
6,609
-14,763
-69% -$2.07M 0.02% 667
2025
Q1
$3.14M Sell
21,372
-3,646
-15% -$528K 0.04% 480
2024
Q4
$3.28M Buy
25,018
+3,485
+16% +$488K 0.04% 480
2024
Q3
$3.36M Buy
21,533
+1,463
+7% +$236K 0.04% 457
2024
Q2
$3.13M Buy
20,070
+4,220
+27% +$635K 0.03% 475
2024
Q1
$2.15M Sell
15,850
-701
-4% -$92.8K 0.02% 610
2023
Q4
$2.23M Buy
16,551
+5,324
+47% +$692K 0.03% 572
2023
Q3
$1.52M Buy
11,227
+153
+1% +$20.9K 0.02% 652
2023
Q2
$1.59M Sell
11,074
-1,266
-10% -$186K 0.02% 659
2023
Q1
$1.71M Buy
12,340
+328
+3% +$44.1K 0.03% 591
2022
Q4
$1.63M Buy
12,012
+59
+0.5% +$7.4K 0.03% 588
2022
Q3
$1.31M Buy
11,953
+449
+4% +$57K 0.02% 625
2022
Q2
$1.54M Buy
11,504
+3,618
+46% +$475K 0.03% 535
2022
Q1
$1.05M Buy
+7,886
New +$946K 0.02% 711

Other funds holding AZN